Skip to content
GLP-1 Savers
Menu
Ranked #254 · Watch List

Longevixx review

Semaglutide at $199 a month with tirzepatide at $299, advertised from $149 — a figure the checkout itself labels a first-month discount, sitting directly beneath a promise that the price never changes.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $199/mo

Save ~85% vs brand-name

$199/mo month-to-month, charged every 30 days ($149 is the first month only)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The homepage ticker says "from $149/mo" and a second block says "from $129/mo". Neither is a rate. The $149 is what the checkout itself labels "$50 off first month" on a $199 standing price, and the $129 belongs to a low-dose program that never names its molecule. Above the card whose price rises after month one sits the line "Same price · All dosages · No hidden fees · Everything included", which is true of the dose and false of the month. There are four programs in all — semaglutide at $199, tirzepatide at $299, a low-dose injectable at $129 and a daily oral at $229 — but the last two are hidden behind a collapsed control and the oral program has no public page at all.

How much does Longevixx cost?

The price Longevixx publishes is $199/mo month-to-month, charged every 30 days ($149 is the first month only). Tirzepatide is listed at $299/mo month-to-month, charged every 30 days. We flag this one to watch: confirm the ongoing rate with Longevixx before you count on it, because a low first month can step up afterward. That works out about 85% under our ~$1,349/mo brand-name cash reference.

Semaglutide
$199/mo month-to-month, charged every 30 days ($149 is the first month only)
Tirzepatide
$299/mo month-to-month, charged every 30 days
Coverage
All 50 states claimed, no list published
Brand-name
Compounded only

The Value Score card

Longevixx scored on our six published factors. See the methodology.

Lowest Real Price76/100
No Teaser-Rate Bait30/100
Both Molecules98/100
Nationwide Availability72/100
Easy Cancellation82/100
Reputation67/100

Why it's a deal

  • The full ladder is visible at the checkout before payment, including the two programs the marketing hides: $199 and $299 standing, $129 for the low-dose injectable and $229 for the daily oral
  • The billing cadence is stated exactly rather than implied — charged every thirty days — and an electronic notice is sent five to seven days before each transaction, which is the warning most subscriptions do not give
  • Cancellation is one action in the account: turn off auto-refill up to forty-eight hours before the processing date, stated once and in the terms rather than in marketing copy
  • A real legal entity, a street address and a phone number are published, and clinical hours are stated rather than implied
  • Nineteen peptide programs are priced publicly on the same site, so the company demonstrably can publish a price list and does

Read the fine print

  • The advertised price is an introductory price. Every public surface says "from $149/mo" and the checkout labels that exact figure "$50 off first month" against a standing $199 — a $600-a-year gap between the number that recruits and the number that bills
  • The line "same price, all dosages, no hidden fees, everything included" is printed directly above a card whose price rises after month one
  • The low-dose and daily oral programs never name the molecule they contain, on any surface, and the oral program has no public page at all — it exists only behind a collapsed control in the checkout
  • No compounding pharmacy, no medical group and no clinician is named anywhere, and neither 503A nor 503B appears on the domain at all
  • Coverage is claimed as fifty states on the marketing pages, described as "the states where it is licensed" on the contact page and "the states where we're available" in the treatment questions, with no list anywhere
  • Patient counts and ratings disagree across the site — two different patient totals and three different average ratings — and no review platform is named for any of them
  • The checkout promises access to the care team around the clock while the published clinical hours are weekdays only
  • A promise that nothing is charged if a patient is not approved appears on the homepage with no matching clause anywhere in the terms

The bottom line

Best for: Shoppers who want a low-dose or daily oral option alongside the standard doses, and who will budget from the renewal price rather than the ticker. Semaglutide at $199 a month with tirzepatide at $299, advertised from $149 — a figure the checkout itself labels a first-month discount, sitting directly beneath a promise that the price never changes.

Ranked #254 of 418 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Longevixx, out of 417 others we track.

Shopping Longevixx against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Longevixx, and every program that undercuts or outscores it — starting with Transparent Meds, the closest match on score — is ranked on the Longevixx alternatives ranking.

More programs we track (24)

387 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Longevixx's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Longevixx's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals